ArticleProceedings. IEEE International Conference on Bioinformatics and Biomedicine2025
Uncovering the Role of Neuropsychiatric Symptoms in Cognitive Impairment Progression.
Article in Proceedings. IEEE International Conference on Bioinformatics and Biomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
With the growing prevalence of cognitive impairment, early detection has become increasingly critical. Prior studies have examined the association between neuropsychiatric symptoms (NPS) and cognitive impairment, identifying potential predictive relationships. However, they hardly evaluated the heterogeneous relationships between serial patterns of NPS and evolving cognition status of the patients. To address this limitation, we investigate the statistical causal relationship between NPS and cognitive impairment, as well as the dynamic changes in their predictive effects over time, with a specific focus on sex differences. Our approach accounts for the fluctuating nature of NPS and varying follow-up durations across participants by implementing a bootstrap strategy that repeatedly samples a fixed number of visits per participant in a temporal order. Then, we apply causal discovery techniques and counterfactual framework-based causal inference methods to estimate the independent effects of NPS over time. Our findings highlight apathy as a key predictive symptom of cognitive impairment. Moreover, its predictive effect peaks earlier in females than in males, indicating that early-stage tracking is particularly informative in female participants. This suggests sex-specific monitoring strategies may improve early detection and intervention of cognitive impairment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.